Interestingly, a recent paper69 reported a similar reduction in myotonia of 1° upon 12.5 mg/kg (similar dose as ours) 10 days after injection of an ON targeting the CUG repeats, while our therapeutic approach aims to block miRNAs that repress MBNL1 expression. Here, MBNL1 is linked to Myotonia.